Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Risk of acquisition of human diarrhoeagenic Escherichia coli virulence genes in intercontinental travellers: A prospective, multi-centre study.

van Hattem JM, Cabal A, Arcilla MS, Alvarez J, de Jong MD, Melles DC, Penders J; COMBAT consortium, Schmidt CG, Schultsz C.

Travel Med Infect Dis. 2019 Jan 1:101362. doi: 10.1016/j.tmaid.2018.12.005. [Epub ahead of print]

PMID:
30609386
2.

Carriage of Blastocystis spp. in travellers - A prospective longitudinal study.

van Hattem JM, Arcilla MS, Schultsz C, Bootsma MC, Verhaar N, Rebers SP, Goorhuis A, Grobusch MP, Penders J, de Jong MD, van Gool T, Bart A; COMBAT consortium.

Travel Med Infect Dis. 2019 Jan - Feb;27:87-91. doi: 10.1016/j.tmaid.2018.06.005. Epub 2018 Jun 19.

3.

Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction.

Matamoros S, van Hattem JM, Arcilla MS, Willemse N, Melles DC, Penders J, Vinh TN, Thi Hoa N; COMBAT consortium, de Jong MD, Schultsz C.

Sci Rep. 2017 Nov 10;7(1):15364. doi: 10.1038/s41598-017-15539-7.

4.

Travel-related acquisition of diarrhoeagenic bacteria, enteral viruses and parasites in a prospective cohort of 98 Dutch travellers.

van Hattem JM, Arcilla MS, Grobusch MP, Bart A, Bootsma MC, van Genderen PJ, van Gool T, Goorhuis A, van Hellemond JJ, Molenkamp R, Molhoek N, Oude Lashof AM, Stobberingh EE, de Wever B, Verbrugh HA, Melles DC, Penders J, Schultsz C, de Jong MD.

Travel Med Infect Dis. 2017 Sep;19:33-36. doi: 10.1016/j.tmaid.2017.08.003. Epub 2017 Aug 24.

5.

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.

Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, Goorhuis A, Grobusch MP, Lashof AMO, Molhoek N, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

Lancet Infect Dis. 2017 Jan;17(1):78-85. doi: 10.1016/S1473-3099(16)30319-X. Epub 2016 Oct 14.

PMID:
27751772
6.

Prolonged carriage and potential onward transmission of carbapenemase-producing Enterobacteriaceae in Dutch travelers.

van Hattem JM, Arcilla MS, Bootsma MC, van Genderen PJ, Goorhuis A, Grobusch MP, Molhoek N, Oude Lashof AM, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

Future Microbiol. 2016 Jul;11:857-64. doi: 10.2217/fmb.16.18. Epub 2016 Jun 30.

7.

Dissemination of the mcr-1 colistin resistance gene.

Arcilla MS, van Hattem JM, Matamoros S, Melles DC, Penders J, de Jong MD, Schultsz C; COMBAT consortium.

Lancet Infect Dis. 2016 Feb;16(2):147-9. doi: 10.1016/S1473-3099(15)00541-1. Epub 2015 Dec 18. No abstract available. Erratum in: Lancet Infect Dis. 2016 Feb;16(2):143.

PMID:
26711361
8.

International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review.

Hassing RJ, Alsma J, Arcilla MS, van Genderen PJ, Stricker BH, Verbon A.

Euro Surveill. 2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30074. Review.

9.

Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.

Chen HJ, Sun J, Huang Z, Hou H Jr, Arcilla M, Rakhilin N, Joe DJ, Choi J, Gadamsetty P, Milsom J, Nandakumar G, Longman R, Zhou XK, Edwards R, Chen J, Chen KY, Bu P, Wang L, Xu Y, Munroe R, Abratte C, Miller AD, Gümüş ZH, Shuler M, Nishimura N, Edelmann W, Shen X, Lipkin SM.

Nat Biotechnol. 2015 Jun;33(6):656-60. doi: 10.1038/nbt.3239. Epub 2015 May 25.

10.

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM.

Cancer Prev Res (Phila). 2015 Mar;8(3):222-30. doi: 10.1158/1940-6207.CAPR-14-0148. Epub 2015 Jan 20.

11.

The Carriage Of Multiresistant Bacteria After Travel (COMBAT) prospective cohort study: methodology and design.

Arcilla MS, van Hattem JM, Bootsma MC, van Genderen PJ, Goorhuis A, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

BMC Public Health. 2014 Apr 28;14:410. doi: 10.1186/1471-2458-14-410.

12.

Severe leptospirosis in a Dutch traveller returning from the Dominican Republic, October 2011.

Arcilla M, Wismans PJ, van Beek-Nieuwland Y, van Genderen PJ.

Euro Surveill. 2012 Mar 29;17(13). pii: 20134.

13.

Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapine.

Hamers RL, Wensing AM, Back NK, Arcilla MS, Frissen JP.

Antivir Ther. 2011;16(1):115-8. doi: 10.3851/IMP1683.

PMID:
21311115
14.

Le-x, the spurned antigen of the Lewis blood group system.

Arcilla MB, Sturgeon P.

Vox Sang. 1974;26(5):425-38. No abstract available.

PMID:
4601855
15.

Perinatal expression of the Lewis and secretor blood group systems.

Arcilla MB, Sturgeon P.

Biol Neonate. 1973;22(5):407-20. No abstract available.

PMID:
4778317
16.

Studies on the secretion of blood group substances. II. Observations on the red cell phenotype Le(a-b-x-).

Arcilla MB, Sturgeon P.

Vox Sang. 1973;25(1):72-87. No abstract available.

PMID:
4724511
17.

Lewis and ABH substances in amniotic fluid obtained by amniocentesis.

Arcilla MB, Sturgeon P.

Pediatr Res. 1972 Dec;6(12):853-8. No abstract available.

PMID:
4643534
18.

Studies on the secretion of blood group substances. 1. Observations on the red cell phenotype Le(a+b+x+).

Sturgeon P, Arcilla MB.

Vox Sang. 1970 Apr;18(4):301-22. No abstract available.

PMID:
5528700
19.

Studies on the secretion of blood group substances. I. Observations on the red cell phenotype Le(a+b+x+).

Sturgeon P, Arcilla MB.

Vox Sang. 1970 Apr;18(4):301-22. No abstract available.

PMID:
5426505

Supplemental Content

Loading ...
Support Center